Condition
CIDP - Chronic Inflammatory Demyelinating Polyneuropathy clinical trials and research
As of November 12, 2026, Find a Trial lists 5 CIDP - Chronic Inflammatory Demyelinating Polyneuropathy clinical trials that are recruiting, at sites in 32 countries (most in Germany (4), Italy (2), Spain (2)). 1 was first registered in the last 30 days. By phase: Phase 4 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 32Countries
Newest CIDP - Chronic Inflammatory Demyelinating Polyneuropathy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Multimodal Movement Tracking in CIDP | — | Düsseldorf, North Rhine-Westphalia | Recruiting | Oct 20, 2026 |
| Using a smartwatch to monitor subcutaneous immunoglobulin treatment in CIDP | — | Düsseldorf, North Rhine-Westphalia and 1 other locations | Recruiting | Dec 10, 2025 |
| Empasiprubart versus IVIg for treating CIDP in adults | Phase 3 | Birmingham, Alabama and 106 other locations | Recruiting | Apr 9, 2025 |
| Safety assessment of efgartigimod exposure during pregnancy and breastfeeding | — | Morgantown, West Virginia and 3 other locations | Recruiting | Mar 8, 2024 |
| Comparing subcutaneous and intravenous immunoglobulin treatments for CIDP | Phase 4 | Aalborg and 3 other locations | Recruiting | Oct 19, 2020 |
All recruiting trials (5)
-
Multimodal Movement Tracking in CIDP
This study tests whether high-resolution whole-body motion data from wearable sensors can reveal changes in motor function for adults with CIDP undergoing treatment.
-
Using a smartwatch to monitor subcutaneous immunoglobulin treatment in CIDP
This project will test whether smartwatch data like step counts and activity levels can show disease severity and treatment response in adults with CIDP who are switching from IVIG to subcutaneous immunoglobulin (fSCIG).
-
Empasiprubart versus IVIg for treating CIDP in adults
This trial tests whether empasiprubart works as well as IVIg and is safe for adults with CIDP who currently benefit from IVIg.
-
Safety assessment of efgartigimod exposure during pregnancy and breastfeeding
This study is trying to see if efgartigimod is safe for pregnant women and breastfeeding mothers, and how it affects their babies.
-
Comparing subcutaneous and intravenous immunoglobulin treatments for CIDP
This study is testing whether a new way of giving immunoglobulin treatment under the skin works better than the traditional method through an IV for people with Chronic Inflammatory Demyelinating Polyneuropathy who haven't been treated before.
Related topics
Quick answers
How many CIDP - Chronic Inflammatory Demyelinating Polyneuropathy clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 32 countries. The most sites are in Germany (4 trials), Italy (2 trials), Spain (2 trials), United States (2 trials), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.